Molecular Templates, Inc. (MTEM): Price and Financial Metrics

Molecular Templates, Inc. (MTEM)

Today's Latest Price: $16.09 USD

0.43 (2.75%)

Updated Feb 28 12:00am

Add MTEM to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

MTEM Stock Summary

  • MTEM's price/sales ratio is 24.51; that's higher than the P/S ratio of 94.86% of US stocks.
  • With a year-over-year growth in debt of 330.24%, Molecular Templates Inc's debt growth rate surpasses 94.14% of about US stocks.
  • As for revenue growth, note that MTEM's revenue has grown 120.33% over the past 12 months; that beats the revenue growth of 95.2% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Molecular Templates Inc, a group of peers worth examining would be PGNX, DNN, OMEX, VERU, and PTCT.
  • Visit MTEM's SEC page to see the company's official filings. To visit the company's web site, go to
MTEM Daily Price Range
MTEM 52-Week Price Range

MTEM Stock Price Chart More Charts

MTEM Price/Volume Stats

Current price $16.09 52-week high $18.38
Prev. close $15.66 52-week low $4.51
Day low $14.86 Volume 330,700
Day high $16.20 Avg. volume 317,245
50-day MA $14.48 Dividend yield N/A
200-day MA $9.27 Market Cap 594.83M

Molecular Templates, Inc. (MTEM) Company Bio

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is based in Austin, Texas.

MTEM Latest News Stream

Event/Time News Detail
Loading, please wait...

MTEM Latest Social Stream

Loading social stream, please wait...

View Full MTEM Social Stream

MTEM Price Returns

1-mo 15.51%
3-mo 23.48%
6-mo 219.88%
1-year 226.37%
3-year 128.55%
5-year -66.68%
YTD 15.05%
2019 246.16%
2018 -59.68%
2017 107.02%
2016 -8.33%
2015 -84.91%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6083 seconds.